- Home
- GTES vs GH Comparison
GTES vs GH Comparison
Compare GTES & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTES
- GH
- Stock Information
- Founded
- GTES 1911
- GH 2011
- Country
- GTES United States
- GH United States
- Employees
- GTES N/A
- GH N/A
- Industry
- GTES Industrial Machinery/Components
- GH Medical Specialities
- Sector
- GTES Industrials
- GH Health Care
- Exchange
- GTES Nasdaq
- GH Nasdaq
- Market Cap
- GTES 4.3B
- GH 3.0B
- IPO Year
- GTES 2018
- GH 2018
- Fundamental
- Price
- GTES $16.32
- GH $23.73
- Analyst Decision
- GTES Buy
- GH Strong Buy
- Analyst Count
- GTES 10
- GH 17
- Target Price
- GTES $19.70
- GH $39.31
- AVG Volume (30 Days)
- GTES 3.3M
- GH 2.3M
- Earning Date
- GTES 11-01-2024
- GH 11-04-2024
- Dividend Yield
- GTES N/A
- GH N/A
- EPS Growth
- GTES 10.93
- GH N/A
- EPS
- GTES 0.82
- GH N/A
- Revenue
- GTES $3,473,400,000.00
- GH $643,810,000.00
- Revenue This Year
- GTES N/A
- GH $27.01
- Revenue Next Year
- GTES $4.40
- GH $18.30
- P/E Ratio
- GTES $19.83
- GH N/A
- Revenue Growth
- GTES N/A
- GH 26.20
- 52 Week Low
- GTES $10.68
- GH $15.81
- 52 Week High
- GTES $19.07
- GH $37.04
- Technical
- Relative Strength Index (RSI)
- GTES 38.42
- GH 31.05
- Support Level
- GTES $16.39
- GH $25.51
- Resistance Level
- GTES $18.20
- GH $26.85
- Average True Range (ATR)
- GTES 0.48
- GH 1.07
- MACD
- GTES -0.16
- GH -0.36
- Stochastic Oscillator
- GTES 3.49
- GH 4.32
About GTES Gates Industrial Corporation plc
Gates Industrial Corp PLC is a manufacturer of engineered power transmission and fluid power solutions. The company has two operating segments; Power Transmission and Fluid Power segments. The Power Transmission solutions convey power and control motion. It is used in applications in which belts, chains, cables, geared transmissions, or direct drives transfer power from an engine or motor to another part or system. The Fluid power solutions are used in applications in which hoses and rigid tubing assemblies either transfer power hydraulically or convey fluids, gases, or granular materials from one location to another. The company generates key revenue from the Power Transmission segment.
About GH Guardant Health Inc.
Guardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant OMNI, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease, or MRD, test. In 2022, the company launched a lab-developed test version of Shield, a liquid biopsy for colorectal cancer, or CRC, screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.